Around 70% of the tumor cells are positive for B-cell lymphoma 6 (BCL 6) protein and approximately 80% of tumor cells are positive for B-cell lymphoma/ leukemia 2 protein (BCL-2) [5]. This evidence concerns the gene BCL6 and neoplasm.